Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...
Autolus will evaluate Cellares’ fully automated, high-throughput manufacturing platform in preparation for expansion into new indicationsSOUTH SAN FRANCISCO, Calif. and LONDON, Jan. 06, 2026 (GLOBE ...
Background Medical specialists are integral to the medical workforce and play a pivotal role in referral systems. However, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback